LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 107 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,460 | -52.4% | 94,000 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $215,260 | -5.8% | 94,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $228,420 | +22.1% | 94,000 | -4.1% | 0.01% | +20.0% |
| Q4 2022 | $187,000 | -20.4% | 98,000 | 0.0% | 0.01% | -28.6% |
| Q3 2022 | $235,000 | +29.1% | 98,000 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $182,000 | +2175.0% | 98,000 | +2350.0% | 0.01% | – |
| Q1 2022 | $8,000 | -50.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -15.8% | 4,000 | 0.0% | 0.00% | – |
| Q3 2021 | $19,000 | +5.6% | 4,000 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | -21.7% | 4,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $23,000 | +64.3% | 4,000 | 0.0% | 0.00% | – |
| Q4 2020 | $14,000 | +133.3% | 4,000 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | -25.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -52.9% | 4,000 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $17,000 | 0.0% | 4,000 | -27.3% | 0.00% | 0.0% |
| Q3 2019 | $17,000 | -50.0% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $34,000 | +13.3% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $30,000 | -18.9% | 5,500 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $37,000 | -37.3% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $59,000 | -10.6% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $66,000 | +40.4% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $47,000 | -41.2% | 5,500 | -31.2% | 0.00% | +100.0% |
| Q4 2017 | $80,000 | +263.6% | 8,000 | +344.4% | 0.00% | 0.0% |
| Q3 2017 | $22,000 | -26.7% | 1,800 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $30,000 | -16.7% | 1,800 | -28.0% | 0.00% | 0.0% |
| Q1 2017 | $36,000 | +260.0% | 2,500 | +257.1% | 0.00% | – |
| Q4 2016 | $10,000 | -23.1% | 700 | 0.0% | 0.00% | – |
| Q3 2016 | $13,000 | +30.0% | 700 | 0.0% | 0.00% | – |
| Q2 2016 | $10,000 | -81.8% | 700 | -84.7% | 0.00% | -100.0% |
| Q1 2016 | $55,000 | -45.5% | 4,571 | -39.6% | 0.00% | -33.3% |
| Q4 2015 | $101,000 | – | 7,571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |